Literature DB >> 24580122

GANRA-5 protects both cultured cells and mice from various radiation types by functioning as a free radical scavenger.

H Pei1, W Chen, W Hu, M Zhu, T Liu, J Wang, G Zhou.   

Abstract

The radio-protective effects of the oxazolone derivative chemical compound 4-(4-methoxy-3-methoxyphenyl-methyl)-2-phenyl- 5(4H)-oxazolone (GANRA-5) against different types of radiation including X-rays, carbon ion beams, microwaves and ultraviolet light (UV) were studied. Cell proliferation/cytotoxicity assay and colony-forming assay were conducted to evaluate the toxicity of GANRA-5. To test its influence on the induction of double-stranded break (DSB) formation and genomic instability, γH2AX focus-forming assay as well as cytokinesis-block micronucleus assay was utilized. Our results indicate that GANRA-5 exhibits low toxicity, while providing high radio-protective effects for MRC-5 cells against different types of radiation. We also found that GANRA-5 acts as a free radical scavenger. Our animal studies provided evidence that GANRA-5 significantly increases the survival rate of mice after X-ray irradiation. Analyses of hemogram, visceral index and detection of superoxide dismutase (SOD) and malondialdehyde (MDA) in the viscera indicate both low toxicity of GANRA-5, combined with its ability to shield radiation risk. In conclusion, our results suggest that GANRA-5 has the potential to be used as a safe and efficient radio-protectant.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24580122     DOI: 10.3109/10715762.2014.898843

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  2 in total

1.  MiR-21 is involved in radiation-induced bystander effects.

Authors:  Shuai Xu; Nan Ding; Hailong Pei; Wentao Hu; Wenjun Wei; Xurui Zhang; Guangming Zhou; Jufang Wang
Journal:  RNA Biol       Date:  2014       Impact factor: 4.652

Review 2.  Radioprotective agents to prevent cellular damage due to ionizing radiation.

Authors:  Tyler A Smith; Daniel R Kirkpatrick; Sean Smith; Trevor K Smith; Tate Pearson; Aparna Kailasam; Kortney Z Herrmann; Johanna Schubert; Devendra K Agrawal
Journal:  J Transl Med       Date:  2017-11-09       Impact factor: 5.531

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.